Gentamicin
- Product NDC
- 63323-010
- 11-digit product format
- 633230010
- Labeler code
- 63323
- Product ID
- 63323-010_092ee018-3026-4c10-a751-2043e980b09f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GENTAMICIN SULFATE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA062366
- Marketing category
- ANDA
- Marketing start
- 2000-08-10
- Substance
- GENTAMICIN SULFATE
- Active strength
- 40 mg/mL
- Pharmacologic classes
- Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Gentamicin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| GENTAMICIN SULFATE | 40 mg/mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 8X7386QRLV |
| Rxcui | 313996 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63323-010-01 | Gentamicin | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | | 7 |
| 63323-010-02 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | | 7 |
| 63323-010-03 | Gentamicin | 20 mL in 1 VIAL | INJECTION, SOLUTION | 20 | | 7 |
| 63323-010-20 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | | 7 |
| 63323-010-41 | Gentamicin | 2 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 2 | | 4 |
| 63323-010-42 | Gentamicin | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | | 4 |
| 63323-010-94 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | | 4 |
| 63323-010-95 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | | 4 |
| 63323-010-96 | Gentamicin | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | | 3 |
| 63323-010-96 | Gentamicin | 20 mL in 1 VIAL, MULTI-DOSE | INJECTION, SOLUTION | 20 | | 3 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| GENTAMICIN SULFATE | ACTIVE INGREDIENT | 8X7386QRLV | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| GENTAMICIN | ACTIVE MOIETY | T6Z9V48IKG | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| SODIUM METABISULFITE | INACTIVE INGREDIENT | 4VON5FNS3C | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| SULFURIC ACID | INACTIVE INGREDIENT | O40UQP6WCF | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 | |
| GENTAMICIN SULFATE | ACTIVE INGREDIENT | 8X7386QRLV | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| GENTAMICIN SULFATE | ACTIVE INGREDIENT | 8X7386QRLV | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| GENTAMICIN | ACTIVE MOIETY | T6Z9V48IKG | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| GENTAMICIN | ACTIVE MOIETY | T6Z9V48IKG | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| SODIUM METABISULFITE | INACTIVE INGREDIENT | 4VON5FNS3C | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| SODIUM METABISULFITE | INACTIVE INGREDIENT | 4VON5FNS3C | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| SULFURIC ACID | INACTIVE INGREDIENT | O40UQP6WCF | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| SULFURIC ACID | INACTIVE INGREDIENT | O40UQP6WCF | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63323-010 | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC
] | 7 | Current NDC, Legacy NDC, 4 package rows | 20231215_a73a5453-c091-43fd-aae2-d992152363b1.zip |
| 63323-010 | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC
] | 4 | Current NDC, Legacy NDC, 4 package rows | 20231219_0cce2238-28d3-4280-b520-ffc3067a2ffa.zip |
| 63323-010 | GENTAMICIN (GENTAMICIN SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 3 | Current NDC, Legacy NDC, 2 package rows | 20241017_84f5c763-1cd3-4d85-9afb-934db8666fbf.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63323-010-01 | 63323001001 | 2 mL in 1 VIAL | 2 ml | | | | | Historical |
| 63323-010-02 | 63323001002 | 25 VIAL in 1 TRAY (63323-010-02) / 2 mL in 1 VIAL (63323-010-01) | 25 vial | 2000-08-10 | 0000-00-00 | No | No | Current |
| 63323-010-03 | 63323001003 | 20 mL in 1 VIAL | 20 ml | | | | | Historical |
| 63323-010-20 | 63323001020 | 25 VIAL in 1 TRAY (63323-010-20) / 20 mL in 1 VIAL (63323-010-03) | 25 vial | 2000-08-10 | 0000-00-00 | No | No | Current |
| 63323-010-41 | 63323001041 | 2 mL in 1 VIAL, MULTI-DOSE | 2 ml | | | | | Historical |
| 63323-010-42 | 63323001042 | 20 mL in 1 VIAL, MULTI-DOSE | 20 ml | | | | | Historical |
| 63323-010-94 | 63323001094 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-010-94) / 2 mL in 1 VIAL, MULTI-DOSE (63323-010-41) | | 2000-08-10 | 0000-00-00 | No | No | Current |
| 63323-010-95 | 63323001095 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-010-95) / 20 mL in 1 VIAL, MULTI-DOSE (63323-010-42) | | 2000-08-10 | 0000-00-00 | No | No | Current |
| 63323-010-96 | 63323001096 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-010-96) / 20 mL in 1 VIAL, MULTI-DOSE | | 2000-08-10 | 0000-00-00 | No | No | Current |